BioNeutra International, Ltd. (BIMO)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
BioNeutra International, Ltd. (BIMO) with AI Score 44/100 (Weak). SuperVision Entertainment, Inc. , operating as BioNeutra International, Ltd. , focuses on high-tech alternate power systems and environmental products. Market cap: 0, Sector: Industrials.
Last analyzed: Mar 18, 2026BioNeutra International, Ltd. (BIMO) Industrial Operations Profile
BioNeutra International, Ltd., formerly SuperVision Entertainment, operates within the industrials sector, focusing on alternate power systems and environmental products. The company's activities include the development of SuperMag technology and film production, positioning it as a diversified entity within the conglomerates industry.
Investment Thesis
Investing in BioNeutra International, Ltd. (BIMO) presents a speculative opportunity, given its involvement in both technology and entertainment sectors. Key value drivers include the potential commercialization of its SuperMag technology and the success of its film productions. However, the company's negative P/E ratio of -0.24 and high beta of 3.42 indicate significant risk and volatility. Growth catalysts depend on securing funding for technology development and achieving box office success. Investors should carefully consider the risks associated with OTC-listed companies and the lack of dividend payments.
Based on FMP financials and quantitative analysis
Key Highlights
- The company operates in the industrials sector with a focus on alternate power systems and environmental products.
- BioNeutra's key technology is SuperMag, aimed at generating electricity from magnetic fields.
- The company is also involved in film production, diversifying its business activities.
- The stock trades on the OTC market, indicating higher risk and lower liquidity compared to major exchanges.
- The company has a negative Price-to-Earnings ratio of -0.24, suggesting it is not currently profitable.
Competitors & Peers
Strengths
- Involvement in both technology and entertainment sectors.
- Focus on developing innovative technologies like SuperMag.
- Established presence in Edmonton, Canada.
- Diversified business model.
Weaknesses
- OTC listing indicates higher risk and lower liquidity.
- Negative P/E ratio suggests unprofitability.
- High beta indicates significant volatility.
- Dependence on successful commercialization of SuperMag technology.
Catalysts
- Upcoming: Potential breakthroughs in SuperMag technology development could drive investor interest.
- Upcoming: Successful film releases could generate revenue and improve the company's financial performance.
- Ongoing: Government incentives for renewable energy technologies could provide financial support.
- Ongoing: Strategic partnerships and acquisitions could expand the company's capabilities and market reach.
Risks
- Potential: Failure to commercialize SuperMag technology could negatively impact the company's prospects.
- Potential: Negative P/E ratio and high beta indicate financial instability and volatility.
- Ongoing: Limited financial disclosure and OTC listing increase investment risk.
- Ongoing: Intense competition in the technology and entertainment sectors.
- Potential: Economic downturn could affect consumer spending and investment in the company.
Growth Opportunities
- Development and Commercialization of SuperMag Technology: The company's SuperMag technology, which aims to generate electricity from magnetic fields, presents a significant growth opportunity. If successfully developed and commercialized, this technology could tap into the growing market for renewable energy solutions. The market size for renewable energy is projected to reach billions of dollars in the coming years. The timeline for commercialization depends on securing funding and achieving technological breakthroughs.
- Expansion into Environmental Products: BioNeutra's focus on environmental products aligns with the increasing demand for sustainable solutions. The company could expand its product line to include a wider range of environmental technologies, such as waste management systems and pollution control devices. The market for environmental products is expected to grow as governments and businesses prioritize sustainability initiatives. The timeline for expansion depends on market research and product development.
- Film Production and Distribution: BioNeutra's involvement in film production offers a growth opportunity in the entertainment industry. The company could produce and distribute films that align with its brand and values, such as documentaries on environmental issues or stories about technological innovation. The global film market is a multi-billion dollar industry, offering significant potential for revenue generation. The timeline for film production depends on securing funding and completing the production process.
- Strategic Partnerships and Acquisitions: BioNeutra could pursue strategic partnerships and acquisitions to expand its capabilities and market reach. Partnering with other companies in the energy or entertainment sectors could provide access to new technologies, markets, and distribution channels. Acquisitions could allow the company to acquire complementary businesses and expand its product line. The timeline for partnerships and acquisitions depends on identifying suitable targets and negotiating favorable terms.
- Government Incentives and Subsidies: The company could leverage government incentives and subsidies to support its research and development activities. Governments around the world are offering financial incentives to companies that are developing renewable energy technologies and environmental products. BioNeutra could apply for grants, tax credits, and other forms of financial assistance to reduce its costs and accelerate its growth. The timeline for securing government incentives depends on the application process and the availability of funding.
Opportunities
- Growing demand for renewable energy solutions.
- Expanding market for environmental products.
- Potential for strategic partnerships and acquisitions.
- Leveraging government incentives for green technologies.
Threats
- Intense competition in the technology and entertainment sectors.
- Technological obsolescence.
- Economic downturn affecting consumer spending.
- Regulatory changes impacting the energy and environmental industries.
Competitive Advantages
- Proprietary SuperMag technology (if proven viable).
- Diversified business model spanning technology and entertainment.
- Established presence in Edmonton, Canada.
About BIMO
BioNeutra International, Ltd., originally incorporated as SuperVision Entertainment, Inc. in 1984, is based in Edmonton, Canada. The company's primary focus is on developing and providing high-tech alternate power systems and environmental products. A key offering is their SuperMag technology, which aims to generate electricity from magnetic fields. In addition to its technological ventures, BioNeutra is also involved in film production, including a film centered around the rise of a new King of Canada and the United States. The company's evolution reflects a blend of technological innovation and entertainment, operating within the industrials sector as a conglomerate.
What They Do
- Develops high-tech alternate power systems.
- Offers environmental products.
- Focuses on SuperMag technology for electricity generation.
- Produces films.
- Operates within the industrials sector.
- Functions as a conglomerate with diverse business activities.
Business Model
- Develops and patents technology related to alternate power systems.
- Generates revenue through the sale of environmental products.
- Produces films for distribution and revenue generation.
Industry Context
BioNeutra International, Ltd. operates within the industrials sector, specifically as a conglomerate. This sector includes companies with diverse business activities, often spanning multiple industries. The market for alternate power systems and environmental products is growing, driven by increasing demand for sustainable energy solutions. However, the competitive landscape is intense, with established players and emerging startups vying for market share. BioNeutra's success depends on its ability to innovate and commercialize its technologies effectively.
Key Customers
- Businesses seeking alternate power solutions.
- Consumers interested in environmental products.
- Film distributors and audiences.
Financials
Chart & Info
BioNeutra International, Ltd. (BIMO) stock price: Price data unavailable
Latest News
No recent news available for BIMO.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BIMO.
Price Targets
Wall Street price target analysis for BIMO.
MoonshotScore
What does this score mean?
The MoonshotScore rates BIMO's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry ConglomeratesLeadership: Ian R. Jamieson
CEO
Ian R. Jamieson serves as the CEO of BioNeutra International, Ltd. His background includes experience in management and leadership roles. Further details regarding his specific career history, educational background, and previous roles are currently unavailable. His expertise is expected to guide the company's strategic direction and operational execution.
Track Record: Information regarding Ian R. Jamieson's specific achievements, strategic decisions, and company milestones during his tenure as CEO is not available. Assessing his track record requires further information on the company's performance and strategic initiatives under his leadership.
BIMO OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that may not meet minimum financial standards or have chosen not to provide regular disclosures. Unlike stocks listed on major exchanges like the NYSE or NASDAQ, OTC Other stocks often have limited regulatory oversight and may lack readily available financial information. This tier is characterized by higher risk and speculative investments, requiring careful due diligence.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in BIMO.
- Lower liquidity can lead to price volatility and difficulty in trading shares.
- The OTC Other tier has less regulatory oversight, increasing the risk of fraud or mismanagement.
- The company's financial performance is uncertain due to limited information.
- The success of the company depends on the commercialization of its technology and film production.
- Verify the company's financial statements and disclosures.
- Assess the company's management team and their experience.
- Evaluate the viability of the company's SuperMag technology.
- Research the company's film production projects and their potential for success.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues involving the company.
- The company has been incorporated since 1984.
- The company has a registered office in Edmonton, Canada.
- The company is involved in technology development and film production.
- The company has a CEO in place.
What Investors Ask About BioNeutra International, Ltd. (BIMO)
What does BioNeutra International, Ltd. do?
BioNeutra International, Ltd., formerly SuperVision Entertainment, Inc., operates as a conglomerate focused on developing high-tech alternate power systems and environmental products. Its core technology, SuperMag, aims to generate electricity from magnetic fields. Additionally, the company produces films, diversifying its business model across technology and entertainment sectors. Based in Edmonton, Canada, BioNeutra seeks to innovate in both sustainable energy and media production.
What do analysts say about BIMO stock?
As of 2026-03-18, there is no readily available analyst coverage for BioNeutra International, Ltd. (BIMO) due to its OTC listing and limited financial disclosure. Key valuation metrics such as revenue growth, profitability, and cash flow are difficult to assess without reliable financial reports. Investors should conduct thorough due diligence and consider the risks associated with investing in OTC stocks before making any investment decisions.
What are the main risks for BIMO?
The main risks for BioNeutra International, Ltd. include its OTC listing, which implies lower liquidity and higher volatility compared to major exchanges. The company's limited financial disclosure increases the risk of investing, as it is difficult to assess its financial health and operational performance. Additionally, the success of the company depends on the commercialization of its SuperMag technology and the success of its film productions, both of which are subject to uncertainty and competition.
What are the key factors to evaluate for BIMO?
BioNeutra International, Ltd. (BIMO) currently holds an AI score of 44/100, indicating low score. Key strength: Involvement in both technology and entertainment sectors.. Primary risk to monitor: Potential: Failure to commercialize SuperMag technology could negatively impact the company's prospects.. This is not financial advice.
How frequently does BIMO data refresh on this page?
BIMO prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven BIMO's recent stock price performance?
Recent price movement in BioNeutra International, Ltd. (BIMO) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Involvement in both technology and entertainment sectors.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider BIMO overvalued or undervalued right now?
Determining whether BioNeutra International, Ltd. (BIMO) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying BIMO?
Before investing in BioNeutra International, Ltd. (BIMO), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is limited due to the company's OTC listing and disclosure status.
- Financial data may not be readily available or reliable.
- The AI analysis is pending and may provide further insights.